Skip to content

A study to assess the effectiveness of a Topical Climate-Adaptive Hydration & Barrier Support Lotion under Controlled Climate Challenge Conditions on different skin parameters.

A Clinical Study to Assess the Effects of Topical Climate-Adaptive Hydration & Barrier Support Lotion on Skin Hydration, Barrier Function, and Erythema Under Controlled Climate Challenge Conditions. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/113097
Enrollment
50
Registered
2026-06-29
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Truvetta Daily Shield AM Moisturizer: Approx. 50 mg, Neat, Single application on volar forearms Intervention2: Truvetta Over Night Repair PM Moisturizer: Approx. 50 mg, Neat, Single a

Sponsors

Suchex Solutions LLP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy adult males and non-pregnant or non-lactating females with age group of 18 to 50 years. 2.Participants with self-declared dry and or sensitive skin. 3.Participants in good general health, as determined by the Investigator based on medical history. 4.Participants with intact, healthy skin at the designated test sites, free from cuts, abrasions, active dermatoses, or dermatological conditions. 5.Female participants of childbearing potential must have a negative urine pregnancy test performed at enrollment visit.

Exclusion criteria

Exclusion criteria: 1.Participants using Body milk or lotion or cream, cosmetics or any other body moisturizing product 3-5 days prior to study. 2.Participants with blemishes, excessive hair, moles, pigmentation, marks e.g., tattoos, scars, and sunburn, open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the test sites that can interfere with the reading. 3.Participants with known allergy or sensitivity to cosmetic products and or any ingredients of the test product, bar cleansing products, creams or lotions, artificial jewellery, or similar items. 4.Participants who are on systemic medication or any medications would compromise the study. 5.Chronic illness which may influence the cutaneous state. 6.Any other condition which could warrant exclusion from the study, as per the Dermatologist or investigator discretion.

Design outcomes

Primary

MeasureTime frame
Instrumental Assessment for Skin HydrationTimepoint: Evaluation at Baseline, Evaluation at 02 hours plus 05 mins, 04 hours plus 05 mins, and 06:15 hours plus 05 mins after product application, Evaluation immediately after completion of tape-stripping, Evaluation at approximately 6 hrs., post tape stripping and at approximately 17 hrs., post tape stripping to confirm recovery after tape-stripping

Secondary

MeasureTime frame
Instrumental Assessment for skin barrier functionTimepoint: Evaluation at Baseline, Evaluation at 02 hours plus 05 mins, 04 hours plus 05 mins, & 06:15 hours plus 05 mins after product application, Evaluation immediately after completion of tape-stripping, Evaluation at approximately 6 hrs., post tape stripping & at approximately 17 hrs., post tape stripping to confirm recovery after tape-stripping;Instrumental Assessment for skin erythemaTimepoint: Evaluation at Baseline, Evaluation at 02 hours plus 05 mins, 04 hours plus 05 mins, & 06:15 hours plus 05 mins after product application, Evaluation immediately after completion of tape-stripping, Evaluation at approximately 6 hrs., post tape stripping & at approximately 17 hrs., post tape stripping to confirm recovery after tape-stripping;Assessment for Itching & StingingTimepoint: 06:15 hours plus 05 mins after product application

Countries

India

Contacts

Public ContactDr Parth Joshi

Cliantha Research

bpatel3@cliantha.com9825618138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026